Apolipoproteins E < Apomorphine < Apoptosis

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]

Ident.	Authors (with country if any)	Title
000310 (2016)	Serdar Durdagi [Turquie] ; Ramin Ekhteiari Salmas [Turquie] ; Matthias Stein [Allemagne] ; Mine Yurtsever [Turquie] ; Philip Seeman	Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques.
000D59 (2010)	M. Lafreniere-Roula [Canada] ; O. Darbin ; W D Hutchison ; T. Wichmann ; A M Lozano ; J O Dostrovsky	Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients.
000E68 (2009)	Atsuko Nagano-Saito [Canada] ; Jiaqiang Liu ; Julien Doyon ; Alain Dagher	Dopamine modulates default mode network deactivation in elderly individuals during the Tower of London task.
001077 (2007)	Elena I. Miklyaeva [Canada] ; Ian Q. Whishaw ; Bryan Kolb	A golgi analysis of cortical pyramidal cells in the unilateral parkinson rat: absence of change in the affected hemisphere vs hypertrophy in the intact hemisphere.
001095 (2006)	Evelyn F. Field [Canada] ; Gerlinde A. Metz ; Sergio M. Pellis ; Ian Q. Whishaw	Sexually dimorphic postural adjustments during vertical behaviour are altered in a unilateral 6-OHDA rat model of Parkinson's disease.
001113 (2006)	Rohita Sharma [Canada] ; Catherine R. Mcmillan ; Catherine C. Tenn ; Lennard P. Niles	Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease.
001141 (2006)	G. Rasouli [Canada] ; M. Rasouli ; F A Lenz ; L. Verhagen ; D S Borrett ; H C Kwan	Fractal characteristics of human Parkinsonian neuronal spike trains.
001176 (2005)	Kelly K. Meissner [Canada] ; David L. Kirkham ; Laurie C. Doering	Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's.
001177 (2005)	Gerlinde A. Metz [Canada] ; Arthur Tse ; Mark Ballermann ; Lori K. Smith ; Karim Fouad	The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.
001189 (2005)	William J. Weiner [États-Unis]	Research update on Parkinson's disease and other movement disorders: highlights from the Eighteenth Annual Symposium on the Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders, October 3, 2004, Toronto, Ontario, Canada.
001284 (2004)	Gerlinde A. Metz [Canada] ; Dionne M. Piecharka ; Jeffrey A. Kleim ; Ian Q. Whishaw	Preserved ipsilateral-to-lesion motor map organization in the unilateral 6-OHDA-treated rat model of Parkinson's disease.
001421 (2003)	Patricia Vergara-Aragon ; Claudia L R. Gonzalez ; Ian Q. Whishaw	A novel skilled-reaching impairment in paw supination on the "good" side of the hemi-Parkinson rat improved with rehabilitation.
001467 (2002)	Raúl De La Fuente-Fernández [Canada] ; Anthony G. Phillips ; Mariangela Zamburlini ; Vesna Sossi ; Donald B. Calne ; Thomas J. Ruth ; A Jon Stoessl	Dopamine release in human ventral striatum and expectation of reward.
001519 (2001)	R. De La Fuente-Fernández [Canada] ; T J Ruth ; V. Sossi ; M. Schulzer ; D B Calne ; A J Stoessl	Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease.
001522 (2001)	R. Levy [Canada] ; J O Dostrovsky ; A E Lang ; E. Sime ; W D Hutchison ; A M Lozano	Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease.
001532 (2001)	R. De La Fuente-Fernández [Canada] ; A S Lim ; V. Sossi ; J E Holden ; D B Calne ; T J Ruth ; A J Stoessl	Apomorphine-induced changes in synaptic dopamine levels: positron emission tomography evidence for presynaptic inhibition.
001566 (2000)	A M Lozano [Canada] ; A E Lang ; R. Levy ; W. Hutchison ; J. Dostrovsky	Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine.
001594 (2000)	J M Van Kampen [Canada] ; E G Mcgeer ; A J Stoessl	Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
001669 (1999)	T L Sourkes [Canada]	"Rational hope" in the early treatment of Parkinson's disease.
001765 (1997)	W D Hutchinson [Canada] ; R. Levy ; J O Dostrovsky ; A M Lozano ; A E Lang	Effects of apomorphine on globus pallidus neurons in parkinsonian patients.
001775 (1997)	D D Newman [Canada] ; N. Rajakumar ; B A Flumerfelt ; A J Stoessl	A kappa opioid antagonist blocks sensitization in a rodent model of Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i -k "Apomorphine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Mesh.i  \
                -Sk "Apomorphine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Apomorphine
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022